Open access · CC-BY
via OpenAlex
Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma
Ajay Kumar, Pritish Nilednu, Azad Kumar, Nilesh Kumar Sharma
Tumor Biology · 2017 · ▲ 4 citations
Telomere attrition
Epigenetic alterations
Cellular senescence
Stem-cell exhaustion
Telomerase activation
Human
Review
Abstract
In the last decade, implications of human telomerase reverse transcriptase (hTERT), a component of ribonucleoprotein telomerase in aging, senescence(definition), and stem cell are highly evident. Besides, the activation of hTERT is also being documented several cancer types including carcinoma. The awakening of telomerase during carcinoma initiation and development is being seen with different perspectives including genetic and epigenetic tools and events. In view of several tumor progenitors genes (also referred as epigenetic mediators), telomerase is placed as key enzyme to achieve the carcinoma phenotype and sustain during the progression. It is true that swaying of telomerase in carcinoma could be facilitated with dedicated set of epigenetic modulators and modifiers players. These epigenetic alterations are heritable, potentially reversible, and seen as the epigenetic signature of carcinoma. Several papers converge to suggest that DNA methylation, histone modification, and small non-coding RNAs are the widely appreciated epigenetic changes towards hTERT modulation. In this review, we summarize the contribution of epigenetic factors in the telomerase activation and discuss potential avenues to achieve therapeutic intervention in carcinoma.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1177/1010428317695951
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Kumar, A., Nilednu, P., Kumar, A., & Sharma, N.K. (2017). Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma. <em>Tumor Biology</em>. https://doi.org/10.1177/1010428317695951
Vancouver
Kumar A, Nilednu P, Kumar A, Sharma NK. Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma. Tumor Biology. 2017. doi:10.1177/1010428317695951.
BibTeX
@article{ajay2017Epigen,
title = {Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma},
author = {Ajay Kumar and Pritish Nilednu and Azad Kumar and Nilesh Kumar Sharma},
journal = {Tumor Biology},
year = {2017},
doi = {10.1177/1010428317695951},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in immunology 2026
Open access · OA
Towards a personalized perspective on gliomas: an epigenetic-immuno-inflammatory aging framework.
Annals of the New York Academy of Sciences 2007
Citation only
Cross‐Talk between Aging and Cancer: The Epigenetic Language
Journal of Biomedical Science 2018
Open access · CC-BY
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer
Journal of Cancer Research and Clinical Oncology 2000
Preprint · OA
Telomere shortening in gastric carcinoma with aging despite telomerase activation
British Journal of Cancer 2004
Open access · CC-BY
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours
Protein & Cell 2010
Open access · OA